Selzentry 150 MG Oral Tablet
- RxCUI
- 729201
- RxNorm name
- Selzentry 150 MG Oral Tablet
- Display name
- Selzentry 150 MG Oral Tablet
- Full name
- Selzentry 150 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:56
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SELZENTRY | MARAVIROC | A-S Medication Solutions | 3c52dddd-0457-41cd-99e0-d30d4fd00ec5 | 2023-11-10 | Boxed warning, Warnings, Adverse reactions | 729201 |
| SELZENTRY | MARAVIROC | ViiV Healthcare Company | 46f30ac5-c96b-429e-976d-8c5ee1c0761b | 2022-09-26 | Boxed warning, Warnings, Adverse reactions | 729201 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 46f30ac5-c96b-429e-976d-8c5ee1c0761b | Selzentry 150 MG Oral Tablet | PSN | 25 | These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 2007 | 20220926 |
| 46f30ac5-c96b-429e-976d-8c5ee1c0761b | maraviroc 150 MG Oral Tablet [Selzentry] | SBD | 25 | These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 2007 | 20220926 |
| 46f30ac5-c96b-429e-976d-8c5ee1c0761b | Selzentry 150 MG Oral Tablet | SY | 25 | These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 2007 | 20220926 |
| 3c52dddd-0457-41cd-99e0-d30d4fd00ec5 | Selzentry 150 MG Oral Tablet | PSN | 4 | These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 2007 | 20231110 |
| 3c52dddd-0457-41cd-99e0-d30d4fd00ec5 | maraviroc 150 MG Oral Tablet [Selzentry] | SBD | 4 | These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 2007 | 20231110 |
| 3c52dddd-0457-41cd-99e0-d30d4fd00ec5 | Selzentry 150 MG Oral Tablet | SY | 4 | These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 2007 | 20231110 |